Low to be honored by American Lung Association for cancer-fighting invention
WEST LAFAYETTE, Ind. —
The American Lung Association in Indiana will honor Purdue University researcher Philip Low on April 13 at its annual gala in Indianapolis for his invention of CYTALUX, which helps in the fight against lung cancer.
Low, Purdue’s Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry in the College of Science, developed CYTALUX, an FDA-approved fluorescent marker that Illuminates lung cancer cells during surgery. This allows surgeons to quickly distinguish malignant cells from healthy cells and confirm that all malignant cells have been removed.
A member of the Purdue Institute for Cancer Research and founder and chief science officer for On Target Laboratories, Low is being recognized with the association’s Legacy Award, which is given to individuals or organizations whose accomplishments have contributed to ending lung cancer.
More information is available on the Purdue Office of Research website.
Media are welcome to share, post and publish these stories, photos and videos.
Media contact: Amy Raley, araley@purdue.edu
More Purdue News
Award-winning writer, documentarian to headline Presidential Lecture Series event, kicking off Purdue’s celebration of America’s 250th
February 9, 2026
Leading writer, the CEOs of AMD and Adobe, and a tech industry investor to headline Presidential Lecture Series spring lineup
February 2, 2026
Purdue’s online master’s degrees in engineering and education achieve top spots in national rankings, making significant gains
January 27, 2026
Purdue recognized with 2026 Carnegie Community Engagement Classification
January 27, 2026